The field of medicine is one of the most advanced in terms of how new treatments and methods have been developed. One of the technologies that is analyzing and making medical evolution more malleable is Additive Manufacturing.

With this technology, at CIM UPC we work to respond to the demands of personalization in the world of health. The main fields of application of the 3D Printing for Health line are:

  • Printing of medical prostheses.
  • 3D tissue bioprinting.
  • Printing of surgical and pre-surgical prototypes and models.
  • Printing biocompatible implants.

The 3D Printing for Health line was born after years of collaboration with leading hospitals, such as Hospital Sant Joan de Déu and Parc Taulí, in the processing of medical images and the printing of surgical planning models that have allowed a substantial improvement in addressing risk interventions.

We offer services that include the manufacture of pre-surgical models and prosthesis printing, 3D tissue bioprinting and, in addition, the design and development of custom 3D printing machinery, surpassing the printers that can be found on the market. We are also working on the feasibility of new materials of medical interest to be processed through additive manufacturing.

In this sense, we have been participating in different R+D+I projects for more than five years to take the capabilities of additive manufacturing to the next level in the field of medicine: projects such as James Bone, Match and QuirofAM have meant a change in the paradigm of 3D printing and its application to the medical and surgical world. In the same vein, we have started participating in a new project, INK3D, which is part of the BASE 3D community, coordinated from our center.

In recent months, at CIM UPC we have played a relevant role in the contribution of additive manufacturing technologies to deal with the health crisis experienced due to Covid-19, being a major agent in the European project CAR3D, in which we continue to work to deal with the aftermath of the pandemic..

    Ask for our services

    We help you to make your project a reality. Fill in the form and we will get in touch with you as soon as possible.


    Origami

    James Bone

    Match

    Quirofam

    Car3D

    3PP

    Cluster MAV

    The main objective of the ORIGAMI project is to develop a manufacturing process that combines basic additive manufacturing technologies with post-processing operations. Establishing, in this way, a process capable of producing valuable products for biomedical applications and that, at the same time, manages to reduce manufacturing times.

    The structure obtained is formed by porosity systems for applications in the biomedical sector, using ceramics based on calcium phosphate or silica glass with excellent biological properties and mesh structure designs to optimize its mechanical characteristics, in order to satisfy the needs of some applications of columnar surgery and bone repair of cancer diseases. In this process, the collaboration and development of trabecular structures with the FAME company is essential, since this company contributes its extensive know-how.

    The focus of the project is based on the development of new technology for additive manufacturing processes. This allows us to create biomedical products with high added value that, technologically, may apply to many other sectors in the future.

    The JAMES BONE project is an industrial research project based on the development of custom implants through the use of additive manufacturing technologies. The main objective of the project is to develop a more robust and profitable manufacturing process that can produce complex prostheses and suitable materials, which are resorbable, to be implanted in the human body.

    The project focuses on satisfying the entire range of implants, from mid-range products based on manufacturing technologies for laser sintering using resorbable materials, to high-end implants based on manufacturing technologies for linear electrospinning using anti-inflammatory medicine. and hydroxyapatite with polymers.

    The goal of MATCh is to offer new orthopaedic device designs. SMEs (FAME MED, GTS, EXEMPLARY) provide skills to design new and reliable macroporous glass-ceramic coatings for surface modification of commercial ceramic acetabular cups, leading to the development of a new generation of hip prostheses with functionalities improved.

    One in 150 people will likely need a hip replacement in the next 30 years. To meet this demand, the match project aims to overcome the current drawbacks of prostheses, developing the prototype of an innovative MONOBLOCK ceramic cup; a cup anchored to the bone through a bioactive trabecular coating, glazed on its surface and capable of promoting both primary and long-term osseointegration.

    The QuirofAM project is framed within the Llavor 3D community, which is promoted by the Generalitat of Catalunya to accelerate and develop the adaptation of additive manufacturing in the industrial sector, and co-financed through the ERDF Catalonia 2014-2020 operational program.

    The objective of the QuirofAM project is to transform surgical practice by incorporating additive manufacturing at three levels: surgical test models, guides and implants for reconstruction and bioactive implants for tissue regeneration. One of the most interesting benefits of this technology in the biomedical sector is the individualization of treatments.

    The CAR3D project is a European project to respond to the needs produced by Covid-19. The main objectives of the project are to produce certified and reusable personal protective equipment (PPE) and make it accessible to the entire European territory through a network of suppliers.

    The CAR3D team works to create reference PPE, from design to end-user, for sanitary materials that meet all quality and safety requirements. As well as to achieve adequate coordination with contacts and supply chains already established.

    Official website: CAR3D – Project

    This project is funded by the Ministry of Science and Innovation, and is based on the development of technology using 3D printer technology to study breast cancer cells. This collaborative project is led by the University of Girona, together with BCN3D Technologies and CIM UPC.

    The objective of the research is to advance personalized medicine to treat one of the most aggressive cancer variants, triple negative, developing a technological platform through 3D printing that combines additive manufacturing by filament extrusion and electrospinning for the first time. The aim is to nimbly produce 3D printed structures where the patient’s own triple-negative breast cancer cells (tumoroids) are cultured and grown, more effectively mimicking the real conditions of the disease. Thus, it is possible to quickly test the drugs for the seva cure, it is the selection process of the ideal drug much faster and avoiding there is a process of trial and error that currently conditions the possibilities of survival of the patients. The project is expected to have a high clinical-translational impact that could represent a breakthrough in the development of new preclinical personalized medicine strategies.

    The project consists of developing a systematized process for the manufacture of advanced and personalized solutions with silicone. Experimental development of silicone prototypes using 3D printing technology, to manufacture new products with high added value that enable the diversification of solution portfolios of the members of the MAV Cluster with the entry into new market niches. The project encompasses two main phases: 1. Feasibility study: study and analyze the technical feasibility of the 3D silicone printing process. 2. Systematized process for 3D printing of industrial silicone components.

    Participants: Advanced Materials Cluster (MAV Cluster); Venair, CIM UPC.

    The emerging group BASE3D, coordinated by the CIM UPC, is a group of research centres created to promote research, technological development and innovation in 3D Printing, and which has proposed to increase the TRL (Technology Readiness Level) of various lines manufacturing of additive manufacturing technologies, and that it will do so by executing projects that total a global investment of about € 3.7 million.

    For this, 4 projects have been promoted:

    • LIGHT3D: Laser and Other Light Technologies, led by LEITAT.
    • FUSE3D: Technologies for semi-phase material deposition, led by HSJD.
    • INK3D: Technologies for the deposition of continuous inks, led by the UPC BBT research group.
    • HYBRI3D: Technologies for multi material hybridization, which we lead from the CIM UPC.

    It is 50% co-financed by the European Regional Development Fund 2014-20 of Catalonia with the support of the Department of Research and Universities.